Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Oxcarbazepine (Tolep) for Anticancer Drug-Induced Neuropathy
2006-006669-17Phase 2Completed
- Sponsor
- Innovative Sensor Technology IST AG
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxcarbazepine in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Innovative Sensor Technology IST AG. Primary endpoint: Proportion of patients with ≥1 grade improvement in WHO neuropathy scale after 30 days. Started Feb 2007; status: completed.
02
Drugs
oxcarbazepine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on 2006-006669-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006669-17.